Interpace Biosciences Inc News

8-K: Current report

Nov 14, 2024 05:21

10-Q: Q3 2024 Earnings Report

Nov 9, 2024 05:13

8-K: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results

Nov 7, 2024 05:48

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-1315 Capital II, L.P.(68%),1315 Capital Management II, LLC(68%)

Oct 17, 2024 04:39

SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Ampersand 2018 Limited Partnership(76%),AMP-18 Management Company Limited Partnership(76%), etc.

Oct 17, 2024 04:33

D: Filing D

Oct 17, 2024 04:03

4: Statement of changes in beneficial ownership of securities-10% Owner 1315 Capital II, L.P.

Oct 16, 2024 07:05

4: Statement of changes in beneficial ownership of securities-10% Owner Ampersand 2018 Limited Partnership

Oct 16, 2024 07:05

8-K: Current report

Oct 16, 2024 04:45

DEFA14A: Others

Sep 21, 2024 05:23

DEF 14A: Definitive information statements

Sep 21, 2024 05:22

10-Q: Q2 2024 Earnings Report

Aug 9, 2024 04:20

8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results

Aug 3, 2024 04:36

8-K: Interpace Biosciences Announces First Quarter 2024 Financial and Business Results

May 10, 2024 04:35

10-Q: Q1 2024 Earnings Report

May 10, 2024 04:26

10-K/A: Annual report (Amendment)

Apr 27, 2024 04:45

Interpace Biosciences Inc | 10-K: FY2023 Annual Report

Apr 2, 2024 05:03

Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results

Mar 14, 2024 00:52

Interpace Biosciences Inc | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Douglas M. Singer(5.78%)

Feb 13, 2024 06:06

Interpace Biosciences Inc | 4: Statement of changes in beneficial ownership of securities-Officer McCarthy Christopher

Feb 6, 2024 19:36